Retracted: Efficacy, Safety, and Tumor Marker Inhibition of Apatinib Combined with Conventional Chemotherapy Regimens for Patients with Advanced Triple-Negative Breast Cancer

Detalles Bibliográficos
Autor principal: and Alternative Medicine, Evidence-Based Complementary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307265/
https://www.ncbi.nlm.nih.gov/pubmed/37388035
http://dx.doi.org/10.1155/2023/9879023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307265/
https://www.ncbi.nlm.nih.gov/pubmed/37388035
http://dx.doi.org/10.1155/2023/9879023

Ejemplares similares